Cancers can resist treatment by ‘stealing’ blood vessels from nearby tissues, researchers have found.
Findings from a new study showed tumors can become resistant to drugs over time by learning to take normal blood vessels from surrounding tissue – a process that researchers call vessel co-option. The process of new blood vessel growth – angiogenesis – is important for cancers to grow, and several anti-angiogenic drugs have been developed to combat it.
But cancers often become resistant to these drugs through mechanisms which have been poorly understood.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze